Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance

Q1 2026 net revenue growth year-over year for Acute Care franchise (+32%), including ZYNRELEF® (+27%) and APONVIE® (+50%)Q1 2026 total net ...

Heron Therapeutics, Inc.: Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance

Q1 2026 net revenue growth year-over year for Acute Care franchise (+32%), including ZYNRELEF- (+27%) and APONVIE- (+50%)Q1 2026 total net revenue of $34.7 millionReached settlement with Baxter Health ...

After the Texas floods, the search for victims became an obsession for a dedicated few

Recovery teams like the United Cajun Navy descended on Texas' Guadalupe River in the wake of the 2025 floods to search for ...

The Next Generation of the GLP-1 Revolution Is Already Underway

As the global obesity crisis continues, GLP-1 receptor agonists have rapidly emerged as one of the most important therapeutic breakthroughs in metabolic medicine. SureNano Science is advancing GEP-44 ...
Hosted on MSN

Illness outbreaks and amenity closures challenge cruise lines

Two health incidents: Norovirus sickened over 100 on the Caribbean Princess, and hantavirus linked to the MV Hondius led to ...